DIVINA LEWIS: Open Payments
NPI 1033851373 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,035 in 216 payments from 16 companies in 2025. Trend: 2023 $2,732 · 2024 $3,624 · 2025 $4,035
Food & beverage: $3,935Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 25 | $583 |
| Supernus Pharmaceuticals, Inc. | 44 | $552 |
| Alkermes, Inc. | 32 | $504 |
| Corium, LLC | 24 | $430 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $326 |
| Collegium Pharmaceutical, Inc. | 12 | $306 |
| E.R. Squibb & Sons, L.L.C. | 12 | $227 |
| ABBVIE INC. | 8 | $218 |
| Otsuka America Pharmaceutical, Inc. | 6 | $178 |
| Neurocrine BioSciences, Inc. | 7 | $174 |
Products named: ARISTADA, Qelbree, Azstarys, AUSTEDO XR, CAPLYTA, Jornay PM, COBENFY, REXULTI.
Industry payments across TX — which companies pay providers there.
